Copyright
©The Author(s) 2026.
World J Psychiatry. Feb 19, 2026; 16(2): 112462
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.112462
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.112462
Figure 1
Meta-analysis flow diagram according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines.
Figure 2 Risk of bias assessment using mixed methods appraisal tool (version 2018).
QRS: Quantitative randomized studies; QNRS: Quantitative non-randomized study; QDS: Quantitative descriptive study; C: Can not say.
Figure 3 Forest plot comparing rocuronium-sugammadex and succinylcholine.
A: Forest chart of all included studies (seizure duration); B: Subgroup analysis of studies excluding quantitative descriptive studies; C: Subgroup analysis of quantitative randomized studies; D: In terms of spontaneous breathing time. SMD: Standardized mean difference; CI: Confidence interval.
Figure 4 Funnel plots.
A: Seizure duration; B: Spontaneous breathing.
- Citation: Anand R, Nag DS, Gope RL, Sahoo MK, Bhushan P, Pal BD, Patel R, Shivani S, Bharadwaj MK, Ansari MA. Rocuronium-sugammadex as an alternative muscle relaxant to succinylcholine in electroconvulsive therapy: A meta-analysis. World J Psychiatry 2026; 16(2): 112462
- URL: https://www.wjgnet.com/2220-3206/full/v16/i2/112462.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i2.112462